PedAM
Pediatric Disease Annotations & Medicines
| Disease | lung cancer |
| Symptom | C0153690|bone metastases |
| Sentences | 48 |
| PubMedID- 23158718 | Diagnostic value of (18)f-labeled naf positron emission tomography-computed tomography imaging in the detection of bone metastases in patients with lung cancer before treatment. |
| PubMedID- 22173321 | Inclusion criteria were as follows: fdg-pet or pet/ct and bone scintigraphy was carried out to detect bone metastases in patients with lung cancer, sufficient data were presented to construct a 2 x 2 contingency table, and histopathologic analysis and/or close clinical and imaging follow-up and/or radiographic confirmation by multiple imaging modalities was used as the reference standard. |
| PubMedID- 21281260 | To address the question of whether or not to operate on lung cancer patients with bone metastases, one would want to know the survival prognosis for all patients—not only the ones who (historically) have undergone surgery—as they represent a selected group of patients. |
| PubMedID- 21354739 | A meta-analysis of (1)(8)fdg-pet-ct, (1)(8)fdg-pet, mri and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. |
| PubMedID- 23532208 | Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases. |
| PubMedID- 23667854 | Positron emission tomography (pet)/ct and bone scintigraphy showed multiple hypermetabolic lesions in the lung adjacent to the left ribs, which suggested lung cancer with multiple bone metastases and a recommendation to rule out all metastases of unknown origin. |
| PubMedID- 26316721 | If it is true that serum concentration of igfbp-3 in lung cancer patients with bone metastases is positively correlated with bone pain and ps score, then igfbp-3 may be a new therapeutic target for bone metastases that could reduce stimulation of osteoclast activity by inhibiting the igf system and reduce osteolytic bone metastases; if the second hypothesis is true, then, with the development of new drugs and widely used bisphosphonates or denosumab, monitoring and evaluation of the severity before and after treatment are likely to reveal the dynamic changes of bone metastasis igfbp-3 indicators and provide meaningful evidence of treatment efficacy, thus becoming an evaluation index of bone metastases. |
| PubMedID- 23937907 | Background: the objective of this retrospective analysis is to systematically assess osseous lesions on the basis of a validated scoring system in terms of stability and fractures prior to and following radiotherapy in 338 lung cancer patients with bone metastases in the vertebral column. |
| PubMedID- 20556457 | N-telopeptide of type i collagen is useful for monitoring therapeutic response in non-small cell lung cancer patients with bone metastases. |
| PubMedID- 23466741 | We diagnosed the patient to have lung cancer with multiple bone metastases, brain metastasis, and liver metastasis (ct2an0m1b, stage iv). |
| PubMedID- 20422345 | The aim of this study was to investigate the putative causal role calcineurin could play in the development of lung cancer with bone metastases. |
| PubMedID- 23788879 | There were 6 lung cancer patients with painful bone metastases. |
| PubMedID- 23356713 | The prognosis among lung cancer patients with bone metastases was unfavorable. |
| PubMedID- 26276360 | Risk factors for skeletal-related events (sres) and factors affecting sre-free survival for nonsmall cell lung cancer patients with bone metastases. |
| PubMedID- 23863726 | Use of zoledronic acid for lung cancer with bone metastases - a study on reossification of osteolytic bone metastases. |
| PubMedID- 22307371 | Bisphosphonates: prevention of bone metastases in lung cancer. |
| PubMedID- 22307377 | Concerning diagnostic use, serum bone-specific alkaline phosphatise (bsap), pinp and osteoprotegerin (opg) were repeatedly shown to be associated with synchronous bone metastases in patients with breast or lung cancer, but sensitivity of these markers was too low to suggest that they might be preferred over conventional bone scans for the diagnosis of bone metastases. |
| PubMedID- 24229627 | Summary of "expert consensus for treatment of bone metastases in lung cancer" reviewers meeting. |
| PubMedID- 20959067 | Diagnostic value of bone metabolic markers ictp and bap in lung cancer patients with bone metastases. |
| PubMedID- 20598769 | Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. |
| PubMedID- 25692755 | Osteocalcin serum levels determination probably does not have diagnostic importance in lung cancer patients with suspected bone metastases. |
| PubMedID- 24962716 | Background: to evaluate the efficacy of three-dimensional radiotherapy for non-small cell lung cancer (nsclc) patients with bone metastases. |
| PubMedID- 25054033 | All the sres resulting from bone metastases in patients with lung cancer contribute considerably to hru and efforts to minimise the incidence of bone complications in these patients through appropriate treatments may help reduce this burden. |
| PubMedID- 23560837 | Zoledronic acid in lung cancer with bone metastases: a review. |
| PubMedID- 26137132 | The present study aimed to analyze the clinical characteristics and prognosis-related factors of non-small cell lung cancer (nsclc) patients with bone metastases at the time of diagnosis. |
| PubMedID- 25435935 | The patient who experienced dlt exhibited lung cancer with multiple bone metastases. |
| PubMedID- 24573639 | Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases. |
| PubMedID- 19939491 | Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates. |
| PubMedID- 21365318 | A hip radiograph showed lytic bone lesions, and a chest radiograph showed an expansive excavated lesion in the left lung, suggestive of a lung cancer with bone metastases. |
| PubMedID- 22504693 | Conclusions: a patient with postoperative recurrence of lung cancer associated with multiple bone metastases responded to combination chemotherapy with vnr and zol. |
| PubMedID- 20193263 | Acute myocardial infarction mimicking squamous cell lung cancer with bone metastases due to hypercalcemia: a case report. |
| PubMedID- 22730101 | Background: bone metastases are common in patients with advanced non-small-cell lung cancer (nsclc) and can have devastating consequences. |
| PubMedID- 24000042 | Similarly, 19,077 and 31,954 ivb claims were identified among 10,982 lung cancer patients with bone metastases and among 7,596 prostate cancer patients with bone metastases, respectively. |
| PubMedID- 22357445 | Data are based on kaplan–meier-estimated costs of sre-related care in patients with bone metastases arising from lung cancer who experienced at least one sre (n = 295) . |
| PubMedID- 26131844 | bone metastases in lung cancer. |
| PubMedID- 20559828 | Surgical treatment of bone metastases in patients with lung cancer. |
| PubMedID- 25568572 | The prognosis of lung cancer patients with bone metastases is poor. |
| PubMedID- 23749913 | Carboxy-terminal telopeptide (ctx) and amino-terminal propeptide (pinp) of type i collagen as markers of bone metastases in patients with non-small cell lung cancer. |
| PubMedID- 22993373 | Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases. |
| PubMedID- 25129089 | A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival. |
| PubMedID- 22959122 | Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosis. |
| PubMedID- 23516466 | Elevated serum levels of soluble rankl and opg have been reported in lung cancer patients with bone metastases. |
| PubMedID- 24982847 | Targeted treatments of bone metastases in patients with lung cancer. |
| PubMedID- 24052009 | Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients. |
| PubMedID- 22956190 | Methods: we searched medline, embase, web of science, and the cochrane library databases through november 10, 2011 for controlled trials that included lung cancer patients with bone metastases treated with bisphosphonates. |
| PubMedID- 23661912 | A few studies have reported results pertaining to the occurrence of bone metastasis and of sres among lung cancer patients with bone metastases, but none have focused on older patients. |
| PubMedID- 21688034 | Zoledronic acid is one of the widely used bisphosphonates that has been demonstrated to significantly prevent sres in lung cancer patients with bone metastases. |
| PubMedID- 26064994 | Indeed, studies on peripheral blood mononuclear cells (pbmcs), isolated from patients affected by breast, prostate, and lung cancer with bone metastases, demonstrated an increase of circulating oc precursors in these patients compared to patients without bone metastases and healthy controls . |
Page: 1